Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 6/20 | 0.66 |
| ▸ | GSK3A | P49840 | 4/20 | 0.66 |
| ▸ | GSK3B | P49841 | 4/20 | 0.66 |
| ▸ | CA2 | P00918 | 2/20 | 0.59 |
| ▸ | CA1 | P00915 | 1/20 | 0.59 |
| ▸ | CA4 | P22748 | 1/20 | 0.59 |
| ▸ | CA9 | Q16790 | 1/20 | 0.59 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.51 |
| ▸ | FAAH | O00519 | 4/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.50 |
| ▸ | DAO | P14920 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23926407 | 0.80 | MGLL (0.66) | MGLLGSK3AGSK3BCA2CA1 | |
| SCHEMBL21291908 | 0.80 | MGLL (0.66) | MGLLGSK3AGSK3BCA2CA1 | |
| SCHEMBL19419960 | 0.80 | GSK3A (0.66) | MGLLGSK3AGSK3BCA2CA1 | |
| SCHEMBL20251099 | 0.80 | MGLL (0.66) | MGLLGSK3AGSK3BCA2CA1 | |
| SCHEMBL14677902 | 0.80 | MGLL (0.66) | MGLLGSK3AGSK3BCA2CA1 | |
| SCHEMBL29693886 | 0.79 | KDM4E (0.56) | MGLLGSK3AGSK3BCA2CA1 | |
| SCHEMBL211905 | 0.79 | GSK3A (1.00) | MGLLGSK3AGSK3BCA2CA1 | |
| SCHEMBL4804503 | 0.79 | MGLL (0.78) | MGLLGSK3AGSK3BCA2HSP90AA1 | |
| SCHEMBL6225797 | 0.78 | CA2 (0.60) | MGLLGSK3AGSK3BCA2CA1 | |
| SCHEMBL32665131 | 0.78 | GSK3A (0.62) | MGLLGSK3AGSK3BCA2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250215093-A1 | FUSION PROTEIN COMPRISING AN EGFR-BINDING DOMAIN AND A MASKING DOMAIN | ZYTOX THERAPEUTICS AB (SE) | 2025-07-03 | — | — | US | disclosed |
| EP-4473014-A1 | FUSION PROTEIN COMPRISING AN EGFR-BINDING DOMAIN AND A MASKING DOMAIN | Zytox Therapeutics AB (SE) | 2024-12-11 | — | — | EP | disclosed |
| CN-118647632-A | Fusion proteins comprising EGFR binding and masking domains | 齐托克斯治疗公司 | 2024-09-13 | — | — | CN | disclosed |
| US-20230250160-A1 | BISPECIFIC PROTEIN | HOBER BIOTECH AB (SE) | 2023-08-10 | — | — | US | disclosed |
| WO-2023148388-A1 | FUSION PROTEIN COMPRISING AN EGFR-BINDING DOMAIN AND A MASKING DOMAIN | ZYTOX THERAPEUTICS AB (SE) | 2023-08-10 | — | — | WO | disclosed |
| US-20230107890-A1 | THERAPEUTIC AGENT TARGETING HER2 | HOBER BIOTECH AB (SE) | 2023-04-06 | — | — | US | disclosed |
| EP-4143223-A1 | BISPECIFIC PROTEIN | Hober Biotech AB (SE) | 2023-03-08 | — | — | EP | disclosed |
| CN-115698056-A | Bispecific proteins | 霍伯生物技术公司 | 2023-02-03 | — | — | CN | disclosed |
| EP-4117786-A1 | THERAPEUTIC AGENT TARGETING HER2 | Hober Biotech AB (SE) | 2023-01-18 | — | — | EP | disclosed |
| CN-115397516-A | Therapeutic agents targeting HER2 | 霍伯生物技术公司 | 2022-11-25 | — | — | CN | disclosed |
| WO-2021219818-A1 | BISPECIFIC PROTEIN | HOBER BIOTECH AB (SE) | 2021-11-04 | — | — | WO | disclosed |
| EP-3904378-A1 | BISPECIFIC PROTEIN | Hober Biotech AB (SE) | 2021-11-03 | — | — | EP | disclosed |
| WO-2021180727-A1 | THERAPEUTIC AGENT TARGETING HER2 | HOBER BIOTECH AB (SE) | 2021-09-16 | — | — | WO | disclosed |
| EP-3878515-A1 | THERAPEUTIC AGENT TARGETING HER2 | Hober Biotech AB (SE) | 2021-09-15 | — | — | EP | disclosed |
| WO-2021041874-A1 | BIOFUNCTIONAL THIOPHENE MONOMERS | MARTIN DAVID C (US) | 2021-03-04 | — | — | WO | disclosed |
| US-20070264656-A1 | METHOD OF MANUFACTURING PROBE-IMMOBILIZED CARRIER | CANON KABUSHIKI KAISHA (JP) | 2007-11-15 | — | — | US | disclosed |
| US-20070264656-A1 | METHOD OF MANUFACTURING PROBE-IMMOBILIZED CARRIER | CANON KABUSHIKI KAISHA (JP) | 2007-11-15 | — | — | US | disclosed |
| EP-1203141-A1 | LINKAGE OF AGENTS TO TISSUE | Pericor Science, Inc. (US) | 2002-05-08 | — | — | EP | disclosed |
| WO-2001006829-A2 | LINKAGE OF AGENTS TO TISSUE | PERICOR SCIENCE, INC. (US) | 2001-02-01 | — | — | WO | disclosed |